Sodium in PDB 6j3b: Crystal Structure of Human Dhodh in Complex with Inhibitor 1289
Enzymatic activity of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289
All present enzymatic activity of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289:
1.3.5.2;
Protein crystallography data
The structure of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289, PDB code: 6j3b
was solved by
Y.Yu,
Q.Chen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
48.39 /
1.60
|
Space group
|
P 32 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
90.829,
90.829,
122.754,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
15.7 /
17.6
|
Other elements in 6j3b:
The structure of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289 also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1289
(pdb code 6j3b). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the
Crystal Structure of Human Dhodh in Complex with Inhibitor 1289, PDB code: 6j3b:
Jump to Sodium binding site number:
1;
2;
Sodium binding site 1 out
of 2 in 6j3b
Go back to
Sodium Binding Sites List in 6j3b
Sodium binding site 1 out
of 2 in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1289
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na422
b:37.5
occ:1.00
|
H
|
A:LYS227
|
2.4
|
45.0
|
1.0
|
OD2
|
A:ASP267
|
2.6
|
18.2
|
1.0
|
HA2
|
A:GLY226
|
2.6
|
37.4
|
1.0
|
O
|
A:HOH527
|
2.8
|
42.0
|
1.0
|
N
|
A:LYS227
|
3.0
|
37.5
|
1.0
|
HB2
|
A:LYS227
|
3.2
|
22.9
|
1.0
|
HB2
|
A:ASP267
|
3.2
|
16.5
|
1.0
|
HA
|
A:ASP264
|
3.3
|
16.1
|
1.0
|
CA
|
A:GLY226
|
3.5
|
31.1
|
1.0
|
CG
|
A:ASP267
|
3.5
|
14.4
|
1.0
|
HB3
|
A:ASP267
|
3.5
|
16.5
|
1.0
|
CB
|
A:ASP267
|
3.6
|
13.8
|
1.0
|
C
|
A:GLY226
|
3.7
|
36.4
|
1.0
|
OD1
|
A:ASP264
|
3.7
|
25.1
|
1.0
|
HA3
|
A:GLY226
|
3.8
|
37.4
|
1.0
|
CB
|
A:LYS227
|
3.9
|
19.1
|
1.0
|
CA
|
A:LYS227
|
4.0
|
26.6
|
1.0
|
HG3
|
A:GLN263
|
4.2
|
27.6
|
1.0
|
O
|
A:HOH581
|
4.2
|
35.9
|
1.0
|
HB3
|
A:LYS227
|
4.2
|
22.9
|
1.0
|
HA
|
A:LYS227
|
4.2
|
31.9
|
1.0
|
CA
|
A:ASP264
|
4.3
|
13.4
|
1.0
|
O
|
A:GLN225
|
4.4
|
24.2
|
1.0
|
N
|
A:GLY226
|
4.6
|
29.9
|
1.0
|
OD1
|
A:ASP267
|
4.7
|
16.9
|
1.0
|
O
|
A:GLN263
|
4.7
|
15.3
|
1.0
|
CG
|
A:ASP264
|
4.7
|
24.6
|
1.0
|
N
|
A:ASP264
|
4.9
|
12.9
|
1.0
|
O
|
A:GLY226
|
4.9
|
28.1
|
1.0
|
C
|
A:GLN225
|
4.9
|
25.9
|
1.0
|
O
|
A:ASP264
|
4.9
|
13.9
|
1.0
|
CB
|
A:ASP264
|
5.0
|
15.7
|
1.0
|
|
Sodium binding site 2 out
of 2 in 6j3b
Go back to
Sodium Binding Sites List in 6j3b
Sodium binding site 2 out
of 2 in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1289
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na423
b:14.3
occ:1.00
|
H
|
A:GLY334
|
2.0
|
10.1
|
1.0
|
H
|
A:VAL336
|
2.1
|
9.2
|
1.0
|
HA
|
A:LEU355
|
2.6
|
10.1
|
1.0
|
O2P
|
A:FMN403
|
2.7
|
7.2
|
1.0
|
HB
|
A:VAL336
|
2.7
|
12.1
|
1.0
|
O
|
A:GLN354
|
2.7
|
8.9
|
1.0
|
N
|
A:GLY334
|
2.8
|
8.4
|
1.0
|
HG23
|
A:VAL336
|
2.9
|
13.2
|
1.0
|
N
|
A:VAL336
|
3.0
|
7.7
|
1.0
|
HG23
|
A:VAL333
|
3.1
|
9.7
|
0.7
|
H
|
A:GLY335
|
3.2
|
9.0
|
1.0
|
N
|
A:GLY335
|
3.3
|
7.5
|
1.0
|
HA
|
A:VAL333
|
3.3
|
12.0
|
0.7
|
C
|
A:GLY334
|
3.3
|
8.5
|
1.0
|
CB
|
A:VAL336
|
3.4
|
10.1
|
1.0
|
HA
|
A:VAL333
|
3.4
|
11.2
|
0.3
|
CA
|
A:GLY334
|
3.4
|
9.2
|
1.0
|
CG2
|
A:VAL336
|
3.5
|
11.0
|
1.0
|
CA
|
A:LEU355
|
3.5
|
8.4
|
1.0
|
HB3
|
A:LEU355
|
3.5
|
12.6
|
1.0
|
HA2
|
A:GLY334
|
3.6
|
11.1
|
1.0
|
HG13
|
A:VAL333
|
3.6
|
11.3
|
0.3
|
P
|
A:FMN403
|
3.7
|
9.5
|
1.0
|
O5'
|
A:FMN403
|
3.7
|
7.0
|
1.0
|
HG21
|
A:VAL336
|
3.7
|
13.2
|
1.0
|
C
|
A:GLN354
|
3.7
|
10.0
|
1.0
|
CA
|
A:VAL336
|
3.7
|
9.5
|
1.0
|
O
|
A:HOH591
|
3.8
|
8.7
|
1.0
|
HG12
|
A:VAL333
|
3.8
|
11.3
|
0.3
|
HG22
|
A:VAL333
|
3.8
|
9.7
|
0.7
|
CG2
|
A:VAL333
|
3.9
|
8.1
|
0.7
|
C
|
A:VAL333
|
3.9
|
8.6
|
0.7
|
CB
|
A:LEU355
|
3.9
|
10.5
|
1.0
|
C
|
A:VAL333
|
3.9
|
7.2
|
0.3
|
HB2
|
A:LEU355
|
3.9
|
12.6
|
1.0
|
O
|
A:GLY334
|
3.9
|
8.8
|
1.0
|
C
|
A:GLY335
|
4.0
|
10.2
|
1.0
|
CA
|
A:VAL333
|
4.0
|
10.0
|
0.7
|
O3P
|
A:FMN403
|
4.1
|
8.9
|
1.0
|
H
|
A:TYR356
|
4.1
|
10.9
|
1.0
|
N
|
A:LEU355
|
4.1
|
9.7
|
1.0
|
CA
|
A:GLY335
|
4.1
|
8.0
|
1.0
|
CA
|
A:VAL333
|
4.1
|
9.3
|
0.3
|
CG1
|
A:VAL333
|
4.1
|
9.4
|
0.3
|
O
|
A:VAL336
|
4.3
|
10.1
|
1.0
|
HG22
|
A:VAL336
|
4.3
|
13.2
|
1.0
|
HA3
|
A:GLY334
|
4.4
|
11.1
|
1.0
|
HE2
|
A:LYS345
|
4.4
|
15.8
|
1.0
|
HA2
|
A:GLY335
|
4.5
|
9.6
|
1.0
|
CB
|
A:VAL333
|
4.5
|
9.3
|
0.7
|
HA
|
A:VAL336
|
4.5
|
11.4
|
1.0
|
C
|
A:VAL336
|
4.5
|
11.9
|
1.0
|
C
|
A:LEU355
|
4.6
|
8.8
|
1.0
|
HG21
|
A:VAL333
|
4.6
|
9.7
|
0.7
|
N
|
A:TYR356
|
4.6
|
9.1
|
1.0
|
CG1
|
A:VAL336
|
4.7
|
11.1
|
1.0
|
HB
|
A:VAL333
|
4.8
|
11.2
|
0.7
|
CB
|
A:VAL333
|
4.8
|
6.9
|
0.3
|
H
|
A:GLN354
|
4.8
|
10.3
|
1.0
|
C5'
|
A:FMN403
|
4.9
|
7.2
|
1.0
|
HG11
|
A:VAL336
|
4.9
|
13.3
|
1.0
|
H5'1
|
A:FMN403
|
4.9
|
8.6
|
1.0
|
HA3
|
A:GLY335
|
4.9
|
9.6
|
1.0
|
H
|
A:LEU355
|
4.9
|
11.6
|
1.0
|
HG11
|
A:VAL333
|
5.0
|
11.3
|
0.3
|
HG12
|
A:VAL336
|
5.0
|
13.3
|
1.0
|
|
Reference:
T.Zeng,
Z.Zuo,
Y.Luo,
Y.Zhao,
Y.Yu,
Q.Chen.
A Novel Series of Human Dihydroorotate Dehydrogenase Inhibitors Discovered By in Vitro Screening: Inhibition Activity and Crystallographic Binding Mode. Febs Open Bio V. 9 1348 2019.
ISSN: ESSN 2211-5463
PubMed: 31087527
DOI: 10.1002/2211-5463.12658
Page generated: Tue Oct 8 09:41:25 2024
|